☆ 4.8 Letter

Do endocannabinoids acting via hepatic CB-1 contribute to NAFLD and hepatic insulin resistance?

JOURNAL OF CLINICAL INVESTIGATION (2022)

Journal

JOURNAL OF CLINICAL INVESTIGATION

Volume 132, Issue 1, Pages -

Publisher

AMER SOC CLINICAL INVESTIGATION INC

DOI: 10.1172/JCI155330

Keywords

-

Categories

Medicine, Research & Experimental

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8

Not enough ratings

Secondary Ratings

Novelty

-

Significance

-

Scientific rigor

-

Rate this paper

Recommended

No Data Available

No Data Available

No Data Available

© Peeref 2019-2024. All rights reserved.